Role of the imprinted Igf2 gene in pancreatic development and function
印记 Igf2 基因在胰腺发育和功能中的作用
基本信息
- 批准号:BB/H003312/1
- 负责人:
- 金额:$ 51.99万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2009
- 资助国家:英国
- 起止时间:2009 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The pancreas is a large gland in the body with two very important functions: it makes insulin and digestive enzymes. The part of the pancreas which produces insulin and other hormones is called the endocrine pancreas. The part of the pancreas that produces the digestive enzymes is called the exocrine pancreas. Digestive enzymes break down food into small components allowing it to be easily absorbed from the intestine. Insulin is produced by specialized cells of the endocrine pancreas called beta cells. Insulin controls your sugar levels in the blood and makes sure that the body cells get enough energy and can store it for later use. The pancreas is able to 'sense' the level of sugar in the blood - if too high the beta cells make and secrete more insulin. If the level is too low, it secretes less. There are conditions when not only more insulin is needed but the number of beta cells needs to increase in order to cope with the increased demand for insulin. These circumstances include normal ageing, pregnancy and obesity to mention a few. Failure to increase the number of beta cells in the above conditions can lead to increased levels of sugar in the blood and diabetes. We know little about how the pancreas is able to increase the number of beta cells when needed. Consequently, to determine the factors that control this adaptive process is very important. The aim of this study is to determine precisely how a gene, that we think is a master regulator of pancreatic growth and function, actually works. This gene encodes for a protein that is similar to insulin - it is suggestively called insulin-like growth factor 2 (Igf2). We have preliminary evidence suggesting that Igf2 is an important factor that controls the normal development of the pancreas and makes beta cells multiply when needed. Many of our attempts to decipher mechanisms which are important for human health and disease both rely and benefit from studying animal models. In this study we will use mice because their pancreas is similar to the human one and because we can remove the Igf2 gene in their beta cells or in the entire pancreas, allowing us to understand how this gene works. We can also increase the amount of Igf2 produced by the beta cells or in the entire pancreas. We will study the development and the structure of the pancreas that can not make Igf2 or makes more Igf2 than normal mice. We will pay particular attention to the effect of the lack or excess of Igf2 on development of the pancreas and the number of beta cells during ageing. We will also study how changing the amount of Igf2 affects the way pancreas makes new beta cells during normal pregnancy, during exposure of mice to high-fat diet (to mimic human obesity) or when the pancreas is injured. We will use these experiments to find which other genes are under the control of Igf2. The results of this study will help to understand better how the pancreas develops, how it works during normal circumstances and how it adapts to conditions which increase the demand for insulin.
胰腺是体内的一个大腺,具有两个非常重要的功能:它是胰岛素和消化酶。胰腺产生胰岛素和其他激素的部分称为内分泌胰腺。产生消化酶的胰腺部分称为外分泌胰腺。消化酶将食物分解为小分子,使其很容易从肠中吸收。胰岛素由称为β细胞的内分泌胰腺的专门细胞产生。胰岛素可以控制血液中的糖水平,并确保身体细胞获得足够的能量,并可以储存以供以后使用。胰腺可以“感觉到”血液中的糖水平 - 如果β细胞过高,则可以分泌更多的胰岛素。如果水平太低,它会少分泌。在某些情况下,不仅需要更多的胰岛素,而且需要增加β细胞的数量才能应对胰岛素的需求增加。这些情况包括正常的衰老,怀孕和肥胖症。在上述条件下,未能增加β细胞的数量会导致血液和糖尿病中的糖水平增加。我们对胰腺时如何能够在需要时增加β细胞的数量。因此,确定控制这种适应过程的因素非常重要。这项研究的目的是确切确定一个基因,我们认为是胰腺生长和功能的主要调节因子,实际上是有效的。该基因编码类似于胰岛素的蛋白质 - 暗示称为胰岛素样生长因子2(IGF2)。我们有初步证据表明,IGF2是控制胰腺正常发育并在需要时使β细胞繁殖的重要因素。我们许多尝试破译对人类健康和疾病重要的机制的尝试都依赖并受益于研究动物模型。在这项研究中,我们将使用小鼠,因为它们的胰腺与人类相似,并且因为我们可以在其β细胞或整个胰腺中去除IGF2基因,从而使我们能够了解该基因的工作原理。我们还可以增加β细胞或整个胰腺产生的IGF2量。我们将研究无法制造IGF2或比正常小鼠更多的胰腺的发育和结构。我们将特别注意IGF2缺乏或过量对胰腺发育的影响以及衰老过程中β细胞的数量。我们还将研究改变IGF2的量如何影响胰腺在正常怀孕期间,小鼠暴露于高脂饮食(模仿人类肥胖)或胰腺受伤时的新β细胞的方式。我们将使用这些实验来找到哪些其他基因在IGF2的控制之下。这项研究的结果将有助于更好地理解胰腺的发展方式,在正常情况下的工作方式以及如何适应增加胰岛素需求的疾病。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes.
- DOI:10.1002/emmm.201101105
- 发表时间:2012-08
- 期刊:
- 影响因子:11.1
- 作者:Haley, Victoria L.;Barnes, David J.;Sandovici, Ionel;Constancia, Miguel;Graham, Christopher F.;Pezzella, Francesco;Buehnemann, Claudia;Carter, Emma J.;Hassan, A. Bassim
- 通讯作者:Hassan, A. Bassim
Mesenchyme-derived IGF2 is a major paracrine regulator of pancreatic growth and function.
- DOI:10.1371/journal.pgen.1009069
- 发表时间:2020-10
- 期刊:
- 影响因子:4.5
- 作者:Hammerle CM;Sandovici I;Brierley GV;Smith NM;Zimmer WE;Zvetkova I;Prosser HM;Sekita Y;Lam BYH;Ma M;Cooper WN;Vidal-Puig A;Ozanne SE;Medina-Gómez G;Constância M
- 通讯作者:Constância M
Mesenchymal Igf2 is a major paracrine regulator of pancreatic growth and function
间充质 Igf2 是胰腺生长和功能的主要旁分泌调节剂
- DOI:10.1101/714121
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Hammerle C
- 通讯作者:Hammerle C
Differential genomic imprinting regulates paracrine and autocrine roles of IGF2 in mouse adult neurogenesis.
- DOI:10.1038/ncomms9265
- 发表时间:2015-09-15
- 期刊:
- 影响因子:16.6
- 作者:Ferrón SR;Radford EJ;Domingo-Muelas A;Kleine I;Ramme A;Gray D;Sandovici I;Constancia M;Ward A;Menheniott TR;Ferguson-Smith AC
- 通讯作者:Ferguson-Smith AC
Mesenchyme-derived IGF2 is a major paracrine regulator of pancreatic growth and function
间充质来源的 IGF2 是胰腺生长和功能的主要旁分泌调节剂
- DOI:10.1530/ey.18.14.8
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Hammerle C
- 通讯作者:Hammerle C
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Miguel Constancia其他文献
Non-CpG methylation in the placenta
- DOI:
10.1016/j.placenta.2023.07.123 - 发表时间:
2023-09-07 - 期刊:
- 影响因子:
- 作者:
Cherlyn Tan;Sungsam Gong;Stephen Charnock-Jones;Gordon C.S. Smith;Russell Hamilton;Miguel Constancia - 通讯作者:
Miguel Constancia
Placental endocrine malfunction programs ovarian defects in female murine offspring
- DOI:
10.1016/j.placenta.2019.06.081 - 发表时间:
2019-08-01 - 期刊:
- 影响因子:
- 作者:
Hannah Yong Yong;Sijia Yao;Jorge Lopez-Tello;Efthimia Christoforou;Ionel Sandovici;Miguel Constancia;Amanda Sferruzzi-Perri - 通讯作者:
Amanda Sferruzzi-Perri
The role of the phosphoinositol kinase (PI3K) p110α in regulating placental phenotype and fetal growth
- DOI:
10.1016/j.placenta.2014.06.087 - 发表时间:
2014-09-01 - 期刊:
- 影响因子:
- 作者:
Amanda Sferruzzi-Perri;Jaspreet Khaira;Abigail Fowden;Miguel Constancia - 通讯作者:
Miguel Constancia
The role of the embryonic phosphoinositol kinase (PI3K) p110α in regulating placental phenotype and fetal growth
- DOI:
10.1016/j.placenta.2015.07.243 - 发表时间:
2015-09-01 - 期刊:
- 影响因子:
- 作者:
Amanda Sferruzzi-Perri;Ionel Sandovici;Abigail Fowden;Miguel Constancia - 通讯作者:
Miguel Constancia
Disruption of imprinting at the Igf2-H19 locus in the placental endocrine zone affects maternal systemic metabolism
- DOI:
10.1016/j.placenta.2019.06.147 - 发表时间:
2019-08-01 - 期刊:
- 影响因子:
- 作者:
Jorge Lopez-Tello;Hannah EJ. Yong;Efthimia R. Christoforou;Tina Napso;Ionel Sandovici;Miguel Constancia;Amanda N. Sferruzzi-Perri - 通讯作者:
Amanda N. Sferruzzi-Perri
Miguel Constancia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Miguel Constancia', 18)}}的其他基金
Epigenetic programming of metabolic health across the life-course
整个生命过程中代谢健康的表观遗传编程
- 批准号:
MC_UU_00014/4 - 财政年份:2018
- 资助金额:
$ 51.99万 - 项目类别:
Intramural
The function of the imprinted microRNA-483 in growth, metabolism and cancer
印迹microRNA-483在生长、代谢和癌症中的功能
- 批准号:
MR/J001562/1 - 财政年份:2012
- 资助金额:
$ 51.99万 - 项目类别:
Research Grant
Physiological roles of System A amino acid transporter in fetal growth and development
系统A氨基酸转运蛋白在胎儿生长发育中的生理作用
- 批准号:
BB/I014594/1 - 财政年份:2011
- 资助金额:
$ 51.99万 - 项目类别:
Research Grant
BBSRC David Phillips Fellowship: Role or imprinted nutrient transporters in fetal growth and development
BBSRC David Phillips 奖学金:胎儿生长发育中的作用或印记营养转运蛋白
- 批准号:
BB/B50118X/2 - 财政年份:2007
- 资助金额:
$ 51.99万 - 项目类别:
Research Grant
Epigenetic regulation of gene expression as a mechanism of nutritional programming and developmental origins of health and disease
基因表达的表观遗传调控作为营养规划和健康与疾病发育起源的机制
- 批准号:
BB/D01235X/2 - 财政年份:2007
- 资助金额:
$ 51.99万 - 项目类别:
Research Grant
Epigenetic regulation of gene expression as a mechanism of nutritional programming and developmental origins of health and disease
基因表达的表观遗传调控作为营养规划和健康与疾病发育起源的机制
- 批准号:
BB/D01235X/1 - 财政年份:2006
- 资助金额:
$ 51.99万 - 项目类别:
Research Grant
相似国自然基金
肥胖诱导IGF2基因印记缺失损伤雄性生殖功能的作用和机制研究
- 批准号:82370846
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IGF2印记丢失诱导结直肠癌干细胞自噬促进肿瘤复发转移的机制及其临床应用研究
- 批准号:81903034
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
无抗冻剂超快速冷冻兔睾丸/附睾精子对ICSI胚胎及子代印记基因IGF2/H19表达及甲基化的影响
- 批准号:81860285
- 批准年份:2018
- 资助金额:35.0 万元
- 项目类别:地区科学基金项目
叶酸代谢障碍引起的胚胎发育异常中H19/IGF2印记基因的表观遗传调控机制
- 批准号:81700777
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
IGF2印记表达丢失促进结肠癌干细胞自我更新及干性维持的作用及调控机制研究
- 批准号:81702782
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Obesity and deregulation of imprinted genes in early life
早期生命中的肥胖和印记基因的失调
- 批准号:
8272676 - 财政年份:2010
- 资助金额:
$ 51.99万 - 项目类别:
Disparities in cervical cancer precursors and deregulation of imprinted genes
宫颈癌前兆的差异和印记基因的失调
- 批准号:
8265756 - 财政年份:2010
- 资助金额:
$ 51.99万 - 项目类别:
Obesity and deregulation of imprinted genes in early life
早期生命中的肥胖和印记基因的失调
- 批准号:
8460569 - 财政年份:2010
- 资助金额:
$ 51.99万 - 项目类别:
Obesity and deregulation of imprinted genes in early life
早期生命中的肥胖和印记基因的失调
- 批准号:
8117085 - 财政年份:2010
- 资助金额:
$ 51.99万 - 项目类别:
Disparities in cervical cancer precursors and deregulation of imprinted genes
宫颈癌前兆的差异和印记基因的失调
- 批准号:
8396689 - 财政年份:2010
- 资助金额:
$ 51.99万 - 项目类别: